Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

These three weeds have important medicinal properties and need more research for potential pharmaceutical use.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Recognizing and managing skin-related psychiatric disorders in children is crucial for effective treatment.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Women with PCOS have more emotional and body image issues than healthy women.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Ashy dermatosis may be linked to atopy and thyroid disease and can be treated with topical steroids.

Newborn skin is uniquely prepared to adapt to new environments compared to adult skin.

Finasteride causes lasting fertility decrease in rats.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.